Management of Tinnitus After Baclofen and Naproxen Use
Immediately discontinue or reduce the dose of baclofen and naproxen, as both medications are documented causes of drug-induced tinnitus that typically improves with dose reduction or cessation.
Initial Assessment and Drug Management
Both baclofen and naproxen are established ototoxic medications that can cause tinnitus:
Baclofen: High-dose baclofen (above standard doses) has been specifically reported to cause severe, dose-dependent tinnitus 1. In documented cases, tinnitus persisted until doses were reduced from 180-210 mg/day down to 60-90 mg/day, at which point symptoms resolved 1.
Naproxen: The FDA label explicitly lists tinnitus as an adverse effect occurring in 3-9% of patients 2. Naproxen has also been associated with permanent sensorineural hearing loss in rare cases 3. Clinical trials demonstrate that naproxen causes tinnitus and hearing disturbances more frequently than some alternative NSAIDs 4.
Action Steps:
- Stop or taper both medications immediately if clinically feasible
- If discontinuation is not possible due to underlying conditions, reduce to the lowest effective dose
- Consider alternative medications for the original indication that have lower ototoxic potential
Comprehensive Evaluation
Once the offending medications are addressed, perform a targeted assessment 5:
Critical history elements to elicit:
- Laterality: unilateral vs bilateral (unilateral requires otolaryngology referral)
- Quality: pulsatile vs non-pulsatile (pulsatile requires imaging workup)
- Duration: recent onset vs persistent (≥6 months)
- Associated symptoms: hearing loss, vertigo, focal neurological deficits
- Impact on quality of life: sleep disturbance, anxiety, depression
Physical examination must include:
- Otoscopic examination for cerumen, middle ear pathology, retrotympanic masses
- Cardiovascular examination for bruits
- Neurological examination for focal deficits
Diagnostic Testing
Obtain a comprehensive audiologic examination promptly (within 4 weeks) if tinnitus is unilateral, persistent ≥6 months, or associated with hearing difficulties 5.
Imaging is NOT indicated unless the patient has 5:
- Unilateral tinnitus
- Pulsatile tinnitus
- Focal neurological abnormalities
- Asymmetric hearing loss on audiometry
Management Based on Persistence
If Tinnitus Resolves with Drug Discontinuation:
- No further intervention needed
- Avoid future use of these medications
- Document drug allergy/adverse reaction
If Tinnitus Persists After Drug Discontinuation:
Assess whether tinnitus is "bothersome" (impacts quality of life, sleep, concentration, or causes emotional distress) 5.
For persistent, bothersome tinnitus (≥6 months), implement the following evidence-based interventions:
Education and counseling (recommended for all patients) 5:
- Explain that tinnitus is a symptom, not a disease
- Discuss natural history and management strategies
- Reassure that most patients adapt over time
Cognitive-behavioral therapy (CBT) - STRONGLY RECOMMENDED 5:
- Most robust evidence for improving tinnitus-related distress
- Addresses psychological impact and coping mechanisms
Hearing aid evaluation if audiometry shows hearing loss 5:
- Recommended even for mild hearing loss
- Can improve both hearing and tinnitus symptoms
Sound therapy (optional) 5:
- Background noise, white noise, or masking devices
- May provide symptomatic relief
What NOT to Do
Do NOT prescribe the following for primary tinnitus treatment 5:
- Antidepressants, anticonvulsants, or anxiolytics (unless treating comorbid psychiatric conditions)
- Intratympanic medications
- Ginkgo biloba, melatonin, zinc, or other dietary supplements 5
- Transcranial magnetic stimulation 5
Critical Red Flags Requiring Urgent Referral
Immediate otolaryngology referral if:
- Unilateral tinnitus (rule out vestibular schwannoma)
- Pulsatile tinnitus (evaluate for vascular abnormalities)
- Severe anxiety or depression with suicidal ideation 5
- Asymmetric hearing loss on audiometry
- Focal neurological deficits
Key Clinical Pitfalls
- Do not assume tinnitus will resolve spontaneously while continuing the offending medications—active dose reduction or discontinuation is required 1, 3
- Do not delay audiologic testing in patients with persistent symptoms, as this identifies treatable hearing loss 5
- Do not prescribe medications for tinnitus itself—the evidence shows no benefit and potential harm 5
- Screen for psychiatric comorbidity, as suicide has been reported in tinnitus patients with coexisting psychiatric illness 5